Bank Of Montreal Aurinia Pharmaceuticals Inc. Transaction History

Bank Of Montreal

  • $214 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$10.05 - $22.48 $232,235 - $519,467
-23,108 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$17.78 - $33.08 $410,860 - $764,412
23,108 New
23,108 $527,000
Q3 2021

Nov 12, 2021
SELL
$10.93 - $23.55 $3.15 Million - $6.8 Million
-288,637 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$10.0 - $14.52 $2.89 Million - $4.19 Million
288,637 New
288,637 $3.89 Million

Others Institutions Holding AUPH

# of Institutions
209
Shares Held
58.7M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email